Prevent and treat Malaria

Malaria is the leading killer of children worldwide. This mosquito-borne disease most heavily impacts Sub-Saharan Africa, where an estimated one million people die from malaria annually. Pregnant women are also at increased risk of dying or delivering low birth weight infants due to malaria.

Tracking with disease risk, IMA delivers malaria interventions that target pregnant women and children under five with a package of World Health Organization (WHO)-endorsed strategies that effectively prevent, diagnose and treat malaria. IMA concentrates its malaria work in the Democratic Republic of Congo (DRC) and South Sudan, two countries that experience disproportionate malaria burden. Here, IMA ensures that pregnant women access intermittent preventative therapy (IPTp) to prevent malaria during pregnancy and that they and their young children sleep under long-lasting insecticide-treated nets (LLINs).

At the diagnostic and treatment level, IMA works with health care providers to accurately diagnose malaria through Rapid Diagnostic Tests (RDTs) and to provide Artemisinin-Based Combination Therapy (ACT) treatment. These interventions increase treatment effectiveness and success.